
201 - 500 employees
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
Biotechnology • Healthcare • Pharmaceuticals
ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). The company focuses on transforming the lives of those impacted by cancer through a robust ADC portfolio targeting hematology and solid tumors. Their capabilities include a validated technology platform and a growing research & development toolbox, resulting in an approved product, ZYNLONTA®, for treating diffuse large B-cell lymphoma. Founded in 2011 and based in Lausanne, Switzerland, with operations in London and New Jersey, ADC Therapeutics is committed to confronting cancer and advancing treatment paradigms.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 August 25
Medical Science Liaison supporting antibody-drug conjugate cancer therapies. Building hematology/oncology relationships and delivering scientific insights across the Pacific Northwest territory.
🕒 August 21
Senior clinical physician advancing ADC Therapeutics’ ZYNLONTA antibody-drug conjugate cancer program. Providing medical monitoring, safety oversight, and regulatory inspection readiness remotely.
🕒 July 24
Medical Science Liaison at ADC Therapeutics providing credible scientific info to healthcare professionals. Responsible for developing key relationships and maintaining medical expertise in oncology.